Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 319

1.

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

Festa A, D'Agostino R Jr, Mykkänen L, Tracy RP, Zaccaro DJ, Hales CN, Haffner SM.

Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):562-8.

3.

Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study.

Festa A, D'Agostino R Jr, Mykkänen L, Tracy R, Howard BV, Haffner SM.

Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):605-10.

4.

Proinsulin, intact insulin, and fibrinolytic variables and fibrinogen in healthy subjects. A population study.

Eliasson M, Røder ME, Dinesen B, Evrin PE, Lindahl B.

Diabetes Care. 1997 Aug;20(8):1252-5.

PMID:
9250449
5.

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.

Haffner SM, D'Agostino R Jr, Mykkänen L, Tracy R, Howard B, Rewers M, Selby J, Savage PJ, Saad MF.

Diabetes Care. 1999 Apr;22(4):562-8.

6.

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study.

Diabetes. 2002 Apr;51(4):1131-7.

8.
9.

LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study.

Festa A, D'Agostino R Jr, Mykkänen L, Tracy RP, Hales CN, Howard BV, Haffner SM.

Diabetes Care. 1999 Oct;22(10):1688-93.

10.

Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.

Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A.

Eur J Clin Invest. 2006 May;36(5):345-52.

PMID:
16634839
11.
13.

Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.

Pellmé F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, Taskinen MR, Jansson PA.

Diabetes. 2003 May;52(5):1182-6.

14.

Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity.

Hanley AJ, Festa A, D'Agostino RB Jr, Wagenknecht LE, Savage PJ, Tracy RP, Saad MF, Haffner SM.

Diabetes. 2004 Jul;53(7):1773-81.

15.

Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.

Henkel E, Gallo S, Siegert G, Koehler C, Hanefeld M.

Blood Coagul Fibrinolysis. 2007 Jun;18(4):327-34.

PMID:
17473573
16.
17.

Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study.

Karter AJ, Mayer-Davis EJ, Selby JV, D'Agostino RB Jr, Haffner SM, Sholinsky P, Bergman R, Saad MF, Hamman RF.

Diabetes. 1996 Nov;45(11):1547-55.

PMID:
8866560
18.

Fibrinolytic dysfunction after gestation is associated to components of insulin resistance and early type 2 diabetes in latino women with previous gestational diabetes.

Morimitsu LK, Fusaro AS, Sanchez VH, Hagemann CC, Bertini AM, Dib SA.

Diabetes Res Clin Pract. 2007 Dec;78(3):340-8. Epub 2007 Jun 4.

PMID:
17544539
20.

The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study.

Juhan-Vague I, Morange PE, Frere C, Aillaud MF, Alessi MC, Hawe E, Boquist S, Tornvall P, Yudkin JS, Tremoli E, Margaglione M, Di Minno G, Hamsten A, Humphries SE; HIFMECH Study Group.

J Thromb Haemost. 2003 Nov;1(11):2322-9.

Supplemental Content

Support Center